Stay updated on ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the revision history.
    Difference
    0.1%
    Check dated 2026-03-11T15:15:14.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the older notices (government funding lapse notice and Revision: v3.4.1). These are general site maintenance updates and do not affect the study data or how users view this page.
    Difference
    0.4%
    Check dated 2026-02-11T02:07:41.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice regarding government funding status was added and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T22:19:02.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added a glossary toggle and a new 'Last Update Submitted that Met QC Criteria' label; updated the site revision to v3.4.0 and standardized capitalization of 'No FEAR Act' data, with minor wording changes.
    Difference
    0.2%
    Check dated 2026-01-27T20:48:50.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Minor revision update from v3.3.3 to v3.3.4 was applied; no study-related content changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T15:56:49.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations section updated to include North Dakota, Western Australia, and Veliko Tarnovo (revision 3.3.3). HHS Vulnerability Disclosure and related location entries (North Dakota, Western Australia, Veliko Tarnovo) were removed (revision 3.3.2).
    Difference
    0.4%
    Check dated 2025-12-23T01:29:00.000Z thumbnail image

Stay in the know with updates to ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial page.